Financhill
Buy
74

MO Quote, Financials, Valuation and Earnings

Last price:
$58.34
Seasonality move :
3.39%
Day range:
$58.70 - $59.32
52-week range:
$40.65 - $59.67
Dividend yield:
6.79%
P/E ratio:
8.99x
P/S ratio:
4.95x
P/B ratio:
--
Volume:
8.6M
Avg. volume:
8.6M
1-year change:
34.26%
Market cap:
$99.6B
Revenue:
$20.4B
EPS (TTM):
$6.55

Earnings Data

Next earnings date for MO
Apr 25
2025
Most recent earnings per share
$1.79
Beat by $0.51
(Jan 30/2025)
Consensus Estimate
$1.28
(Jan 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/25/2025 Q1 $4.6B -- -- $1.19 --
01/30/2025 Q4 $5B $5.1B $1.79 $1.28 $0.51
10/31/2024 Q3 $5.3B $5.3B $1.34 $1.35 -$0.01
07/31/2024 Q2 $5.4B $5.3B $2.21 $1.34 $0.87
04/25/2024 Q1 $4.7B $4.7B $1.21 $1.15 $0.06
02/01/2024 Q4 $5.1B $5B $1.17 $1.18 -$0.01
10/26/2023 Q3 -- -- $1.22 $1.30 -$0.08
08/01/2023 Q2 -- -- $1.19 $1.30 -$0.11
04/27/2023 Q1 -- -- $1.00 $1.17 -$0.17
02/01/2023 Q4 -- -- $1.50 $1.16 $0.34
10/27/2022 Q3 -- -- $0.12 $1.30 -$1.18
07/28/2022 Q2 -- -- $0.49 $1.25 -$0.76
04/28/2022 Q1 -- -- $1.08 $1.09 -$0.01
01/27/2022 Q4 -- -- $0.88 $1.08 -$0.20
10/28/2021 Q3 -- -- -$1.48 $1.26 -$2.74
07/29/2021 Q2 -- -- $1.16 $1.17 -$0.01
04/29/2021 Q1 -- -- $0.77 $1.05 -$0.28
01/28/2021 Q4 -- -- $1.03 $1.02 $0.01
10/30/2020 Q3 -- -- -$0.51 $1.16 -$1.67
07/28/2020 Q2 -- -- $1.04 $1.06 -$0.02
04/30/2020 Q1 -- -- $0.83 $0.99 -$0.16
01/30/2020 Q4 -- -- -$1.00 $1.02 -$2.02
10/31/2019 Q3 -- -- -$1.39 $1.15 -$2.54
07/30/2019 Q2 -- -- $1.07 $1.10 -$0.03
04/25/2019 Q1 -- -- $0.60 $0.93 -$0.33
01/31/2019 Q4 -- -- $0.66 $0.95 -$0.29
10/25/2018 Q3 -- -- $1.03 $1.06 -$0.03
07/26/2018 Q2 -- -- $0.99 -- --
04/26/2018 Q1 -- -- $1.00 -- --
02/01/2018 Q4 -- -- $2.59 -- --
10/26/2017 Q3 -- -- $0.97 -- --
07/27/2017 Q2 -- -- $1.03 -- --
05/02/2017 Q1 -- -- $0.72 -- --
02/01/2017 Q4 -- -- $5.26 -- --
10/27/2016 Q3 -- -- $0.56 -- --
07/27/2016 Q2 -- -- $0.84 -- --
04/28/2016 Q1 -- -- $0.62 -- --
01/28/2016 Q4 -- -- $0.64 -- --
10/29/2015 Q3 -- -- $0.78 -- --
07/29/2015 Q2 -- -- $0.74 -- --
04/23/2015 Q1 -- -- $0.52 -- --

Altria Group Earnings Questions

  • How Much did Altria Group Generate in Revenue Last Quarter?

    Altria Group reported $5.1B worth of top line sales in its most recent quarter.

  • Did Altria Group Beat Earnings Last Quarter?

    Altria Group announced earnings per share of $1.79 which represents a beat of analyst forecast a $1.28 per share.

  • Is Altria Group Profitable?

    Altria Group reported $3.6B that represents $2.13 per share over the last quarter.

  • What is the Analyst Consensus for Altria Group EPS Next Year?

    Altria Group's earnings are forecast to decrease from $6.54 per share to $5.14 per share next year representing a decrease of -18.35%.

  • When is Altria Group's Earnings Date?

    Altria Group's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock